Nem Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.60 Cr
as on 01-01-2025
- Paid Up Capital ₹ 1.55 Cr
as on 01-01-2025
- Company Age 40 Year, 13 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 14.92 Cr
as on 01-01-2025
- Revenue -3.74%
(FY 2020)
- Profit 15.96%
(FY 2020)
- Ebitda 0.87%
(FY 2020)
- Net Worth 20.23%
(FY 2020)
- Total Assets 14.02%
(FY 2020)
About Nem Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.60 Cr and a paid-up capital of Rs 1.55 Cr.
The company currently has active open charges totaling ₹14.92 Cr.
Lalit Talati, Siddhi Gandhi, Mukti Jain, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999MH1984PTC034856
- Company No.
034856
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 1984
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationThane, Maharashtra
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nem Laboratories Pvt Ltd offer?
Nem Laboratories Pvt Ltd offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Nem Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalit Talati  | Director | 20-Dec-1984 | Current |
| Siddhi Gandhi | Director | 01-Oct-2008 | Current |
| Mukti Jain | Director | 16-Feb-2010 | Current |
| Dhaval Talati | Director | 20-Mar-2004 | Current |
Financial Performance of Nem Laboratories.
Nem Laboratories Pvt Ltd, for the financial year ended 2020, experienced Minor drop in revenue, with a 3.74% decrease. The company also saw a substantial improvement in profitability, with a 15.96% increase in profit. The company's net worth Soared by an impressive increase of 20.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nem Laboratories?
In 2020, Nem Laboratories had a promoter holding of 41.20% and a public holding of 58.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Mighty Pharma Private LimitedActive 39 years 8 months
Siddhi Gandhi, Mukti Jain and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Oct 2017 | ₹1.75 Cr | Open |
Others Creation Date: 06 Jul 2001 | ₹5.30 Cr | Open |
Canara Bank Creation Date: 06 Jul 2001 | ₹1.40 Cr | Open |
How Many Employees Work at Nem Laboratories?
Nem Laboratories has a workforce of 62 employees as of Apr 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nem Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nem Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
